MétaCan
Menu
Back to cohort
Record W4387376978 · doi:10.1016/j.ajhg.2023.08.014

Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy

2023· review· en· W4387376978 on OpenAlexafffundabout
Kirsten M. Farncombe, Derek Wong, Maia Norman, Leslie E. Oldfield, Julia A. Sobotka, Mark Basik, Yvonne Bombard, Victoria Carile, Lesa Dawson, William D. Foulkes, David Malkin, Aly Karsan, Patricia C. Parkin, Lynette S. Penney, Aaron Pollett, Kasmintan A. Schrader, Trevor J. Pugh, Raymond H. Kim, Adriana Aguilar‐Mahecha, Melyssa Aronson, Nancy N. Baxter, Phil Bedard, Hal K. Berman, Marcus Q. Bernardini, Clarissa Chan, Tulin Cil, Blaise Clarke, Irfan Dhalla, Christine Elser, Gabrielle Ene, Sarah E. Ferguson, Laura Genge, Robert Gryfe, Michelle Jacobson, Monika Kastner, Pardeep Kaurah, Josiane Lafleur, Jordan Lerner‐Ellis, Stéphanie Lheureux, Shelley M. MacDonald, Jeanna McCuaig, Brian Mckee, Nicole Mittmann, Seema Panchal, Carolyn Piccinin, Dean A. Regier, Zoulikha Rezoug, Krista Rideout, Kara Semotiuk, Sara Singh, Lillian L. Siu, Sophie Sun, Emily Thain, Karin Wallace, Thomas R. Ward, Shelley Westergard, Stacy Whittle, Wei Xu, Celeste Yu

Bibliographic record

VenueThe American Journal of Human Genetics · 2023
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Genomics and Diagnostics
Canadian institutionsSinai Health SystemUniversity of British ColumbiaDalhousie UniversityHospital for Sick ChildrenJewish General HospitalSt. Michael's HospitalMount Sinai HospitalPrincess Margaret Cancer CentreSickKids FoundationUniversity of TorontoUniversity Health NetworkToronto General HospitalMcGill UniversityMemorial University of NewfoundlandOntario Institute for Cancer Research
FundersSharks FoundationCanadian Institutes of Health ResearchFDC FoundationCanada Research ChairsUniversity of TorontoCanadian Cancer SocietyGarron Family Cancer CentreCanadian Imperial Bank of CommerceChildren's Tumor FoundationOntario Institute for Cancer ResearchPrincess Margaret Cancer FoundationTerry Fox Research Institute
KeywordsMedicineCancerLynch syndromeLi–Fraumeni syndromeLiquid biopsyGenetic testingMLH1Cancer screeningOncologyGermline mutationInternal medicineGeneticsMutationBiologyDNA mismatch repairGeneColorectal cancer

Abstract

fetched live from OpenAlex

At least 5% of cancer diagnoses are attributed to a causal pathogenic or likely pathogenic germline genetic variant (hereditary cancer syndrome-HCS). These individuals are burdened with lifelong surveillance monitoring organs for a wide spectrum of cancers. This is associated with substantial uncertainty and anxiety in the time between screening tests and while the individuals are awaiting results. Cell-free DNA (cfDNA) sequencing has recently shown potential as a non-invasive strategy for monitoring cancer. There is an opportunity for high-yield cancer early detection in HCS. To assess clinical validity of cfDNA in individuals with HCS, representatives from eight genetics centers from across Canada founded the CHARM (cfDNA in Hereditary and High-Risk Malignancies) Consortium in 2017. In this perspective, we discuss operationalization of this consortium and early data emerging from the most common and well-characterized HCSs: hereditary breast and ovarian cancer, Lynch syndrome, Li-Fraumeni syndrome, and Neurofibromatosis type 1. We identify opportunities for the incorporation of cfDNA sequencing into surveillance protocols; these opportunities are backed by examples of earlier cancer detection efficacy in HCSs from the CHARM Consortium. We seek to establish a paradigm shift in early cancer surveillance in individuals with HCSs, away from highly centralized, regimented medical screening visits and toward more accessible, frequent, and proactive care for these high-risk individuals.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.963
Threshold uncertainty score0.849

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.094
GPT teacher head0.362
Teacher spread0.268 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations17
Published2023
Admission routes3
Has abstractyes

Explore more

Same venueThe American Journal of Human GeneticsSame topicCancer Genomics and DiagnosticsFrench-language works237,207